220 related articles for article (PubMed ID: 27391101)
1. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
Didriksen M; Fejgin K; Nilsson SR; Birknow MR; Grayton HM; Larsen PH; Lauridsen JB; Nielsen V; Celada P; Santana N; Kallunki P; Christensen KV; Werge TM; Stensbøl TB; Egebjerg J; Gastambide F; Artigas F; Bastlund JF; Nielsen J
J Psychiatry Neurosci; 2017 Jan; 42(1):48-58. PubMed ID: 27391101
[TBL] [Abstract][Full Text] [Related]
2. Dependency of prepulse inhibition deficits on baseline startle reactivity in a mouse model of the human 22q11.2 microdeletion syndrome.
Scarborough J; Mueller F; Weber-Stadlbauer U; Richetto J; Meyer U
Genes Brain Behav; 2019 Apr; 18(4):e12523. PubMed ID: 30267483
[TBL] [Abstract][Full Text] [Related]
3. Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine.
Nilsson SRO; Heath CJ; Takillah S; Didienne S; Fejgin K; Nielsen V; Nielsen J; Saksida LM; Mariani J; Faure P; Didriksen M; Robbins TW; Bussey TJ; Mar AC
Transl Psychiatry; 2018 Nov; 8(1):247. PubMed ID: 30429456
[TBL] [Abstract][Full Text] [Related]
4. Layers II/III of Prefrontal Cortex in Df(h22q11)/+ Mouse Model of the 22q11.2 Deletion Display Loss of Parvalbumin Interneurons and Modulation of Neuronal Morphology and Excitability.
Al-Absi AR; Qvist P; Okujeni S; Khan AR; Glerup S; Sanchez C; Nyengaard JR
Mol Neurobiol; 2020 Dec; 57(12):4978-4988. PubMed ID: 32820460
[TBL] [Abstract][Full Text] [Related]
5. Activation of mGluR2/3 receptors in the ventro-rostral prefrontal cortex reverses sensorimotor gating deficits induced by systemic NMDA receptor antagonists.
Valsamis B; Chang M; Typlt M; Schmid S
Int J Neuropsychopharmacol; 2014 Feb; 17(2):303-12. PubMed ID: 24067361
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
Nilsson SR; Fejgin K; Gastambide F; Vogt MA; Kent BA; Nielsen V; Nielsen J; Gass P; Robbins TW; Saksida LM; Stensbøl TB; Tricklebank MD; Didriksen M; Bussey TJ
Cereb Cortex; 2016 Oct; 26(10):3991-4003. PubMed ID: 27507786
[TBL] [Abstract][Full Text] [Related]
7. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724
[TBL] [Abstract][Full Text] [Related]
8. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.
Chun S; Du F; Westmoreland JJ; Han SB; Wang YD; Eddins D; Bayazitov IT; Devaraju P; Yu J; Mellado Lagarde MM; Anderson K; Zakharenko SS
Nat Med; 2017 Jan; 23(1):39-48. PubMed ID: 27892953
[TBL] [Abstract][Full Text] [Related]
9. Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress.
Tripathi A; Spedding M; Schenker E; Didriksen M; Cressant A; Jay TM
Transl Psychiatry; 2020 Jan; 10(1):41. PubMed ID: 32066701
[TBL] [Abstract][Full Text] [Related]
10. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.
Vorstman JA; Turetsky BI; Sijmens-Morcus ME; de Sain MG; Dorland B; Sprong M; Rappaport EF; Beemer FA; Emanuel BS; Kahn RS; van Engeland H; Kemner C
Neuropsychopharmacology; 2009 Feb; 34(3):739-46. PubMed ID: 18769474
[TBL] [Abstract][Full Text] [Related]
11. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
[TBL] [Abstract][Full Text] [Related]
12. Altered auditory processing and effective connectivity in 22q11.2 deletion syndrome.
Larsen KM; Mørup M; Birknow MR; Fischer E; Hulme O; Vangkilde A; Schmock H; Baaré WFC; Didriksen M; Olsen L; Werge T; Siebner HR; Garrido MI
Schizophr Res; 2018 Jul; 197():328-336. PubMed ID: 29395612
[TBL] [Abstract][Full Text] [Related]
13. Reduced amplitude and slowed latency of the acoustic startle response in adolescents and adults with 22q11.2 deletion syndrome.
Parker DA; Imes S; Ruban G; Ousley OY; Henshey B; Massa NM; Walker E; Cubells JF; Duncan E
Schizophr Res; 2024 Jul; 269():9-17. PubMed ID: 38703519
[TBL] [Abstract][Full Text] [Related]
14. Df(h22q11)/+ mouse model exhibits reduced binding levels of GABA
Al-Absi AR; Thambiappa SK; Khan AR; Glerup S; Sanchez C; Landau AM; Nyengaard JR
Mol Cell Neurosci; 2022 Sep; 122():103769. PubMed ID: 35988854
[TBL] [Abstract][Full Text] [Related]
15. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.
Saito R; Koebis M; Nagai T; Shimizu K; Liao J; Wulaer B; Sugaya Y; Nagahama K; Uesaka N; Kushima I; Mori D; Maruyama K; Nakao K; Kurihara H; Yamada K; Kano M; Fukada Y; Ozaki N; Aiba A
Transl Psychiatry; 2020 Feb; 10(1):35. PubMed ID: 32066675
[TBL] [Abstract][Full Text] [Related]
17. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
[TBL] [Abstract][Full Text] [Related]
18. Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders.
Saito R; Miyoshi C; Koebis M; Kushima I; Nakao K; Mori D; Ozaki N; Funato H; Yanagisawa M; Aiba A
Mol Brain; 2021 Apr; 14(1):68. PubMed ID: 33845872
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
Abekawa T; Ito K; Nakagawa S; Koyama T
Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
[TBL] [Abstract][Full Text] [Related]
20. Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers.
Deslauriers J; Larouche A; Sarret P; Grignon S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():156-64. PubMed ID: 23697796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
